Yokogawa and Repligen Join Forces to Advance Process Analytical Technology

September 22, 2025 - 11:52

Yokogawa Corporation of America has announced a strategic collaboration with Repligen to enhance process analytical technology in the bioprocessing sector. This partnership will integrate Yokogawa's OpreX Bio Pilot with Repligen's MAVERICK® system, aiming to improve the automated control of critical parameters such as glucose and lactate levels in cell cultures.

The integration of these advanced technologies is expected to streamline biomanufacturing processes, allowing for more precise monitoring and control during cell culture operations. By combining Yokogawa's expertise in process automation with Repligen's innovative analytical solutions, the collaboration seeks to optimize production efficiency and product quality in biopharmaceutical manufacturing.

This initiative reflects a growing trend in the industry towards automation and real-time monitoring, which are essential for meeting the increasing demands for biopharmaceuticals. The partnership is poised to deliver significant advancements in the way bioprocesses are managed, ultimately benefiting manufacturers and patients alike.